BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11117528)

  • 1. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).
    Webb P; Anderson CM; Valentine C; Nguyen P; Marimuthu A; West BL; Baxter JD; Kushner PJ
    Mol Endocrinol; 2000 Dec; 14(12):1976-85. PubMed ID: 11117528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants required for selective interactions between the thyroid hormone receptor homodimer and the nuclear receptor corepressor N-CoR.
    Kim JY; Son YL; Kim JS; Lee YC
    J Mol Biol; 2010 Feb; 396(3):747-60. PubMed ID: 20006618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode.
    Meng X; Webb P; Yang YF; Shuen M; Yousef AF; Baxter JD; Mymryk JS; Walfish PG
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6267-72. PubMed ID: 15849266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
    Makowski A; Brzostek S; Cohen RN; Hollenberg AN
    Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TR surfaces and conformations required to bind nuclear receptor corepressor.
    Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
    Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
    Seol W; Mahon MJ; Lee YK; Moore DD
    Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.
    Hu X; Lazar MA
    Nature; 1999 Nov; 402(6757):93-6. PubMed ID: 10573424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
    Loinder K; Söderström M
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor.
    Potter GB; Beaudoin GM; DeRenzo CL; Zarach JM; Chen SH; Thompson CC
    Genes Dev; 2001 Oct; 15(20):2687-701. PubMed ID: 11641275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation.
    Li X; Kimbrel EA; Kenan DJ; McDonnell DP
    Mol Endocrinol; 2002 Jul; 16(7):1482-91. PubMed ID: 12089344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
    Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
    Tomita A; Buchholz DR; Shi YB
    Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of nuclear receptor-corepressor interaction.
    Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
    Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
    Burke LJ; Downes M; Laudet V; Muscat GE
    Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
    Cohen RN; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors.
    Downes M; Burke LJ; Bailey PJ; Muscat GE
    Nucleic Acids Res; 1996 Nov; 24(22):4379-86. PubMed ID: 8948627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.